4.6 Meeting Abstract

A molecular signature determines the prognostic and therapeutic subtype of nonmuscle-invasive bladder cancer responsive to intravesical Bacillus Calmette-Guerin therapy

Journal

EUROPEAN UROLOGY
Volume 79, Issue -, Pages S614-S614

Publisher

ELSEVIER

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available